Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 09, 2011
Newton, MA and San Diego, CA – September 8, 2011 -- Allena Pharmaceuticals, Inc., a company developing and commercializing innovative non-systemic oral protein therapeutics to treat metabolic and orphan diseases, and Althea Technologies, a leading ...
read more
Wednesday, October 26, 2011
Sigma-Aldrich Corporation today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), has completed an assessment by SafeBridge® Consultants, Inc. and has been granted SafeBridge Certification for its ...
read more
Tuesday, November 01, 2011
This advanced form of a highly purified novel vaccine, developed by a leading vaccine company in Japan promises to provide highly effective protection from a severely debilitating infection while exhibiting a superior patient safety profile.
read more
Tuesday, November 08, 2011
Sentinel Capital Partners, a private equity firm that invests in promising lower middle market companies, today announced its acquisition of WellSpring Pharmaceutical Corporation, a North American manufacturer and marketer of specialty prescription ...
read more
Monday, November 21, 2011
Beginning in May and lasting through the summer, Germany experienced a historically large outbreak of food-borne E. coli infection, which resulted in more than 800 cases of STEC-HUS (Shiga-toxin producing E. coli hemolytic uremic syndrome), an ultra-...
read more
Genzyme, a Sanofi company, announced today that the European Medicines Agency (EMA) has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta).
“This approval by the EMA represents an important ...
read more
AMRI announced today that the Medicines and Healthcare Regulatory Agency (MHRA) of the UK government has issued a Good Manufacturing Practice (GMP) certificate for AMRI’s manufacturing facility in Holywell, Wales, UK, following an inspection in ...
read more
Patheon and PROCAPS S.A. are pleased to announce an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing services. The offering will be branded as "P-...
read more
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
read more
Monday, February 13, 2012
Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of three non-executive directors to Cobra Biologics’ board, and two business development managers tasked with driving ...
read more
Thursday, February 16, 2012
Catalent Pharma Solutions, a leading global drug delivery technology company, and NewMarket Pharmaceuticals LLC have entered into an agreement to jointly formulate and develop a portfolio of products for treating production and companion animals ...
read more
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ...
read more
Tuesday, February 21, 2012
Jubilant HollisterStier, a subsidiary of Jubilant Life Sciences, announced today that its Contract Manufacturing & Services division has recently secured contracts with four innovator life science companies for the commercial manufacturing of sterile...
read more
Tuesday, February 21, 2012
Service Eliminates Over-Packaging by Providing Deep Knowledge of a
Product’s Stability Barrier Needs Before It Is Packaged . . .
Leading to a “Just Right” Solution for Oral Dose Products in Six Weeks
read more
Wednesday, February 22, 2012
Global pharmaceutical manufacturer, Aesica, experienced significant growth in 2011, doubling both its turnover and its workforce and forming a number of long-term strategic partnerships with customers such as UCB and Noramco.
read more